Caplin Point Laboratories logo

Caplin Point Laboratories results

NSE: CAPLIPOINTBSE: 524742Pharmaceuticals & BiotechnologySmall Cap

Last close ₹2,222.00down ₹27.10 (1.20%)BSE ₹2,222.15

Share price at the NSE close on 23 Oct 2026. Previous close ₹2,249.10.

52-week range of traded prices to 23 Oct 2026
₹1,500.30Low, 30 Mar 2026₹2,990.00High, 24 Sep 2026
Market cap
₹16,890 Cr453rd largest listed
P/E
25.4
P/B
4.7
Dividend yield
0.36%
ROE
20.7%
ROCE
19.8%
Debt to equity
0.00
Volume, NSE
76,90447.0% delivered

Q1 results, quarter to Jun 2026

Consolidated: the company and its subsidiaries together. ₹ crore.Caplin Point Laboratories annual results and balance sheet

Revenue
₹610 Cr+19.6% on a year ago · +1.7% on the quarter before
Operating profit
₹213 Cr+20.1% on a year ago · +4.5% on the quarter before
Net profit
₹179 Cr+18.8% on a year ago · +3.6% on the quarter before
Earnings per share
₹23.27+15.8% on a year ago · +4.0% on the quarter before
Operating margin
35.0%
Net margin
29.3%

From revenue to net profit, ₹ crore

  1. Revenue610
  2. Materials and goods−245
  3. Employee costs−54
  4. Other expenses−98
  5. Operating profit213
  6. Depreciation−22
  7. Other income+34
  8. Finance costs−0.2
  9. Profit before tax225
  10. Tax−46
  11. Joint ventures0.0
  12. Net profit179

Caplin Point Laboratories results by quarter

Consolidated: the company and its subsidiaries together. Latest quarter to Jun 2026. Results for the quarter to Sep 2026 are due by 14 Nov 2026, 45 days after it ends.Results filings and date

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
₹ croreSep 2021Q2Filed 3 NovDec 2021Q3Filed 4 FebMar 2022Q4Filed 13 MayJun 2022Q1Filed 8 AugSep 2022Q2Filed 13 NovDec 2022Q3Filed 13 FebMar 2023Q4Filed 27 MayJun 2023Q1Filed 8 AugSep 2023Q2Filed 13 NovDec 2023Q3Filed 9 FebMar 2024Q4Filed 17 MayJun 2024Q1Filed 8 AugSep 2024Q2Filed 8 NovDec 2024Q3Filed 7 FebMar 2025Q4Filed 10 JunJun 2025Q1Filed 7 AugSep 2025Q2Filed 5 NovDec 2025Q3Filed 5 FebMar 2026Q4Filed 14 MayJun 2026Q1Filed 12 Aug
Revenue from operations304326339346359372389395410436453459483493502510534543600610
202225239244253263265269273293308307318331334332345353396397
Materials and goods bought126144152157165164177179164190191185189195201195210215245245
Employee costs2929303234353635353737404447474347505354
Other expenses4852575454645355736680828589879487889898
Operating profit before depreciation101101100102106109124127137142145152165162168178189190204213
Operating margin33.3%31.0%29.5%29.5%29.4%29.4%31.8%32.0%33.5%32.7%32.0%33.1%34.1%32.9%33.4%34.8%35.4%34.9%34.0%35.0%
Depreciation and amortisation1212111111111111121416161716171618191922
Other income810121416141112201717192131262330342834
Finance costs00000000000000000000
Profit before one-off items and tax9899100105110112124127146145146154169177177184201204213225
One-off items00000000000000000000
Profit before tax9899100105110112124127146145146154169177177184201204213225
2119191918142323302625293837313441384146
Tax rate21.4%19.6%19.1%17.9%16.7%12.8%18.4%17.9%20.5%17.6%17.0%19.1%22.3%21.0%17.8%18.3%20.3%18.7%19.0%20.5%
Share of profit of joint ventures and associates–––––0––00–0000000–0
777981869297101104116120121125131140145151160166173179
Other comprehensive income−101022179−5−210135123−20481777−2
Total comprehensive income76799110810910796102126121124130132163144151208183250177
Net margin25.3%24.3%23.8%24.9%25.6%26.2%26.0%26.4%28.3%27.5%26.7%27.2%27.1%28.4%28.9%29.5%30.0%30.6%28.8%29.3%
Net margin without joint ventures and associates–––––26.2%––28.3%27.5%–27.2%27.1%28.4%28.9%29.5%30.0%30.6%–29.3%
Earnings per share₹9.91₹9.90₹10.43₹11.21₹12.09₹12.86₹13.45₹13.62₹15.13₹15.44₹16.01₹16.32₹17.22₹18.28₹18.75₹20.10₹20.32₹21.56₹22.38₹23.27
Diluted earnings per share₹9.86₹9.81₹10.33₹11.12₹11.99₹12.75₹13.33₹13.55₹15.06₹15.39₹15.90₹16.24₹17.12₹18.19₹18.69₹20.03₹20.25₹21.51₹22.31₹23.21
Earnings per share in rupees, restated for later splits and bonuses.

Filed results, as an XML file each

16 earlier filings

Segment results by quarter

Consolidated, ₹ crore, quarters to Jun 2026.Caplin Point Laboratories segment results by year

  • Rest of the World

    Revenue, ₹ crore
    Profit, ₹ crore
  • USA

    Revenue, ₹ crore
    Profit, ₹ crore
₹ croreSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue of all businesses––––––502510534543600610
Company revenue, as in its results410436453459483493502510534543600610
Revenue––––––406404427433470476
Revenue growth––––––––––15.8%18.0%
Profit––––––135151156160163158
Profit growth––––––––––20.6%4.6%
Margin––––––33.4%37.5%36.6%37.0%34.7%33.3%
Assets––––––1,4491,4891,5881,7201,9182,021
Liabilities––––––269249251273333351
Capital employed––––––1,1801,2391,3371,4471,5861,670
Revenue––––––96107107110130134
Revenue––––––262330342834
Profit is before tax and finance costs, the way companies report their segments.